System identifies more pathogens and antimicrobial resistances than any other

By integrating all necessary pre-analytical and analytical steps into one solution, the recently CE-marked Unyvero system, which is now commercially available in Europe, provides pathogen identification and antibiotic resistance marker information without needing expert staff and a sophisticated infrastructure, its manufacturer Curetis reports. Of even greater interest is its range of targets.

The Unyvero P50 Pneumonia Cartridge for pneumonia diagnostics (interior view)
The Unyvero P50 Pneumonia Cartridge for pneumonia diagnostics (interior view)

‘The first available application is for the diagnosis of pneumonia and it is able to identify 17 pathogens (16 bacteria, 1 fungus) and 22 antibiotic resistance markers in a single, automated run,’ the firm adds. ‘So far, there is no comparable system available on the market that combines the detection of as many pathogens and as many antimicrobial resistances as the Curetis system,’ according to Professor Ingo Autenrieth, Director of the Institute of Medical Microbiology and Hygiene at Tubingen University, who is currently evaluating the system in a multicentre clinical trial. In a performance evaluation using real-world patient samples, the Unyvero System was compared to standard microbiology techniques. It had a better than 95% specificity and identified 74 additional pathogens, e.g. mixed infections, missed by standard microbiology culture.

Further Unyvero Cartridges, e.g. to diagnose surgical site infections, sepsis and tuberculosis, are under development, to provide pathogen and resistance information within four hours and all simply operated by an assistant medical technician or nurse. The system can be placed wherever needed, and also integrated with the hospital information system.

‘The work flow is very easy,’ says Oliver Schacht, CEO of Curetis. ‘Four steps, and you’re done. This simple process with five-minute hands-on time ensures consistent work flow and reduces potential handling errors.’ First, the user transfers the patient’s sample into the Unyvero Sample Tube prefilled with specific reagents. Subsequently, the tube is handled by the Unyvero Lysator, which can process all types of body fluids e.g. sputum, aspirates, lavage samples and protected brush specimens. After lysis, the Unyvero Sample Tube with the processed sample and a Unyvero Master Mix Tube are inserted into the Unyvero Cartridge, which integrates all sample analysis steps to execute a complete test based on endpoint-PCR.

For quality control purposes a synthetic gene alongside each patient sample is processed. ‘As a physically closed system,’ Schacht adds, ‘the cartridge avoids spilling of sample fluids or reagents and minimises contamination risks. After use, it is compatible with standard waste disposal procedures of hospitals and laboratories. ‘Once the cartridge is loaded, the Unyvero Analyzer automatically performs the handling of the Cartridge, including DNA purification, amplification with endpoint PCR and the detection of the target sequences after hybridisation on a special array.’

Both the Unyvero Lysator and the Analyzer are controlled by the Unyvero Cockpit, which also guides the user through the workflow. ‘An integrated bar-code reader enables quick patient information entry and traceability throughout the entire workflow. The software manages automatic results generation and storage and supports users with detection of lot numbers and checking of expiry dates. Results are automatically processed and displayed without requiring any further interaction.’ Details: www.curetis.com.
 

10.07.2012

Read all latest stories

Related articles

Photo

Rapid diagnostics

T2 Biosystems hosts integrated symposium at ECCMID 2019

T2 Biosystems, maker of rapid diagnostic technology to aid in the detection of blood stream infections to prevent sepsis, will host an integrated symposium titled “Rapid Diagnostics Direct from…

Photo

MRSA

Effective screening can kill several birds with one stone

The MRSA problem has been ignored almost stoically in many European countries for the past 20 years. Thus the number of resistant Staphylococci cases exploded from 1% in 1990 around 25% in 2010.…

Photo

Combatting nosocomial infections

A&E Staphylococci POCT

Martin Möckel and Dorothee Riedlinger, from the Charité Medical University Berlin, Emergency and Acute Medicine Campus Virchow-Klinikum, and Campus Charité-Mitte report on POCT testing in the…

Related products

Atlas Genetics - Atlas Genetics io system

Infectious diseases testing

Atlas Genetics - Atlas Genetics io system

Atlas Genetics Ltd
i-Solutions Health – LabCentre

LIS, Middleware, POCT

i-Solutions Health – LabCentre

i-SOLUTIONS Health GmbH
Medat – Laboratory Information System

LIS, Middleware, POCT

Medat – Laboratory Information System

Medat Computer-Systeme GmbH
Siemens Healthineers - syngo Lab Inventory Manager (sLIM)

LIS, Middleware, POCT

Siemens Healthineers - syngo Lab Inventory Manager (sLIM)

Siemens Healthineers